Targeting of miR34a-NOTCH1 axis reduced breast cancer stemness and chemoresistance.
Park EY, Chang E, Lee EJ, Lee HW, Kang HG, Chun KH, Woo YM, Kong HK, Ko JY, Suzuki H, Song E, Park JH.
Park EY, et al. Among authors: ko jy.
Cancer Res. 2014 Dec 15;74(24):7573-82. doi: 10.1158/0008-5472.CAN-14-1140. Epub 2014 Nov 3.
Cancer Res. 2014.
PMID: 25368020